Open AccessPrevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients
Author(s) -
Tatjana Marković,
Ljiljana Jeinić,
Aleksandra Šmitran,
Miroslav Petković
Publication year - 2013
Publication title -
srpski arhiv za celokupno lekarstvo
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 17
eISSN - 2406-0895
pISSN - 0370-8179
DOI - 10.2298/sarh1312775m
Subject(s) - cefepime , cefotaxime , imipenem , microbiology and biotechnology , piperacillin , ampicillin , medicine , amikacin , ceftazidime , beta lactamase , antimicrobial , gentamicin , cefazolin , antibiotic resistance , amoxicillin , drug resistance , escherichia coli , antibiotics , biology , bacteria , pseudomonas aeruginosa , biochemistry , genetics , gene
In Gram-negative bacteria, the production of beta-lactamases is the most important mechanism of resistance to beta-lactam antibiotics. In the Banja Luka region, there were no extensive researches on the prevalence and antimicrobial resistance of the extended-spectrum beta-lactamase (ESBL) producing Escherichia coli (E. coli) isolates.